Week of January 24, 2023 | Vol. 12, Issue 3

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

CPHA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech

13 transactions totaling $822 million


Supplies, Equipment & Services

15 transactions totaling $180 million


Healthcare Facilities & Distributors

6 transactions totaling $32 million


Healthcare IT & Managed Care

4 transactions

PRIVATE PLACEMENTS

Pharma & Biotech

36 transactions totaling $694 million


Supplies, Equipment & Services

20 transactions totaling $247 million


Healthcare Facilities & Distributors

1 transaction


Healthcare IT & Managed Care

16 transactions totaling $67 million

PUBLIC OFFERINGS

Pharma & Biotech

14 transactions totaling $601 million


Supplies, Equipment & Services

6 transactions totaling $1 billion


Healthcare Facilities & Distributors

0 transactions


Healthcare IT & Managed Care

0 transactions

TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.






MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider


Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

A trio of biotechs consolidate as M&A fails to materialize at JPM

Fierce Biotech - Jan 17, 2023

Sanofi inks 5-year deal with Thread to adopt more technology into trials

Fierce Biotech - Jan 17, 2023

BioCentriq Completes Tech Transfer From Avenge Bio

Contract Pharma - Jan 18, 2023

Upperton Pharma Solutions Breaks Ground on New Facility

Contract Pharma - Jan 18, 2023

Sun Pharma to Acquire Concert Pharmaceuticals for $576M

Contract Pharma - Jan 19, 2023

PsychoGenics on board for Iama's preclinical Dravet syndrome therapy study

Fierce Biotech - Jan 19, 2023

Pfizer to Acquire Manufacturing Site in North Carolina from Abzena

Contract Pharma - Jan 20, 2023

Charles River & Rznomics Partner to Initiate Clinical Development of RZ-001

Contract Pharma - Jan 20, 2023

TANNER NEWS

Linkedin  

'A Rare Affair'

Congrats to all those who made this event a great success! Tanner was honored to serve as a gold sponsor in support of the Osteogenesis Imperfecta Foundation alongside other rare disease advocates. Learn more..

Increasing the Efficiency of Clinical Trials

The global generic drugs market is projected to be worth $384.4bn within the next five years. Learn more what it means for both patients and drug manufacturers here.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.